99mTc-N-NOET imaging for myocardial perfusion: can it offer more than we already have?

D Fagret, C Ghezzi, G Vanzetto - Journal of Nuclear Medicine, 2001 - Soc Nuclear Med
Aneutral, lipophilic 99mTc-labeled compound proposed as a myocardial perfusion imaging
agent is 99mTc-(N-ethoxy-N-ethyl-dithiocarbamato) nitrido (N-NOET)(1). 99mTc-N-NOET …

[CITATION][C] Tc-99m N-NOET: Chronicle of a unique perfusion imaging agent and a missed opportunity?

G Vanzetto, D Fagret, C Ghezzi - Journal of Nuclear Cardiology, 2004 - Springer
Technetium 99m (N-ethoxy, N-ethyldithiocarbamato) nitrido (TcN-NOET) is a neutral,
lipophilic Tc-99m–labeled compound that was first proposed as a myocardial perfusion …

Clearance of technetium 99m N-NOET in normal, ischemic-reperfused, and membrane-disrupted myocardium

G Johnson III, IL Allton, KN Nguyen, JM Lauinger… - Journal of Nuclear …, 1996 - Elsevier
Background. Technetium 99m-labeled bis (N-ethoxy, N-ethyl dithiocarbamato) nitrido
technetium (v)(99mTcN-NOET) is a new neutral cardiac perfusion imaging agent that has …

[CITATION][C] Technetium 99m-N-NOET: although not equivalent to thallium-201, it still offers new opportunities

AJ Sinusas - Journal of Nuclear Cardiology, 2000 - Springer
Preliminary clinical studies suggest that bis (N-ethoxy, N-ethyl dithiocardbamato) nitrido
technetium 99m (v)(Tc-99m N-NOET) myocardial perfusion imaging provides comparable …

Optimal timing for initial and redistribution technetium 99m-N-NOET image acquisition

FD Petruzella, M Ruiz, P Katsiyiannis… - Journal of Nuclear …, 2000 - Springer
Background Bis (N-ethoxy, N-ethyl dithiocarbamato) nitrido technetium-99m (V)(Tc-99m-N-
NOET) is a new Tc-99m-labeled myocardial perfusion imaging agent that redistributes. We …

Verapamil does not inhibit 99mTcN-NOET uptake in situ in normal or ischemic canine myocardium

LM Riou, C Ghezzi, G Vanzetto, A Broisat… - Journal of Nuclear …, 2003 - Soc Nuclear Med
Bis (N-ethoxy, N-ethyldithiocarbamato) nitrido technetium (V)(99mTc)(99mTcN-NOET) is a
new myocardial perfusion imaging agent currently undergoing phase III clinical trials in the …

Planar imaging of 99mTc-labeled (bis (N-ethoxy, N-ethyl dithiocarbamato) nitrido technetium (V)) can detect resting ischemia

G Johnson III, KN Nguyen, Z Liu, P Gao… - Journal of Nuclear …, 1997 - Elsevier
Background. 99mTc-labeled (bis (N-ethoxy, N-ethyl dithiocarbamato) nitrido technetium
(V))(99mTcN-NOET) is a new lipophilic, neutral-charge cardiac perfusion imaging agent that …

99mTc-N-NOET Myocardial Uptake Reflects Myocardial Blood Flow and Not Viability in Dogs With Reperfused Acute Myocardial Infarction

G Vanzetto, DK Glover, M Ruiz, DA Calnon… - Circulation, 2000 - Am Heart Assoc
Background—N-Ethoxy-N-ethyl-dithiocarbamato-nitrido-99mTc (99mTc-N-NOET) is a new
neutral lipophilic 99mTc-labeled myocardial perfusion agent with a high first-pass extraction …

Myocardial Uptake and Redistribution of 99mTc-N-NOET in Dogs With Either Sustained Coronary Low Flow or Transient Coronary Occlusion: Comparison With 201 …

G Vanzetto, DA Calnon, M Ruiz, DD Watson… - Circulation, 1997 - Am Heart Assoc
Background 99mTc-N-NOET (NOET) is a new myocardial perfusion imaging agent that
redistributes over time. We sought to better define the redistribution kinetics of NOET using …

Effects of increased lipid concentration and hyperemic blood flow on the intrinsic myocardial washout kinetics of 99mTcN-NOET

LM Riou, S Unger, MC Toufektsian… - Journal of Nuclear …, 2003 - Soc Nuclear Med
Bis (N-ethoxy, N-ethyldithiocarbamato) nitrido technetium (V)(99mTc)(99mTcN-NOET) is a
myocardial perfusion imaging agent demonstrating significant redistribution and currently in …